Page last updated: 2024-10-20

pyrazinamide and Porphyrias

pyrazinamide has been researched along with Porphyrias in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research Excerpts

ExcerptRelevanceReference
"Pyrazinamide was found to be capable of significantly inducing amino-levulinic acid synthetase activity; the other antituberculous drugs caused either slight or no induction of amino-levulinic acid synthetase."1.26Exacerbation of porphyria during treatment of pulmonary tuberculosis. ( Magnussen, CR; Patterson, JR; Treece, GL; Tschudy, DP, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Treece, GL1
Magnussen, CR1
Patterson, JR1
Tschudy, DP1

Other Studies

1 other study available for pyrazinamide and Porphyrias

ArticleYear
Exacerbation of porphyria during treatment of pulmonary tuberculosis.
    The American review of respiratory disease, 1976, Volume: 113, Issue:2

    Topics: 5-Aminolevulinate Synthetase; Adult; Animals; Diet; Enzyme Induction; Humans; Liver; Male; Porphyria

1976